Monoamine oxidase and its inhibition: in honour of Mary L. C. Bernheim
Gespeichert in:
Körperschaft: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Amsterdam
Elsevier/Excerpta Medica/North-Holland
1976
|
Schriftenreihe: | Ciba Foundation symposium
new ser. 39 |
Schlagworte: | |
Beschreibung: | xii, 415 p. |
ISBN: | 0444152059 9021940442 9780470663318 9780470717899 |
Internformat
MARC
LEADER | 00000nam a2200000zcb4500 | ||
---|---|---|---|
001 | BV044848183 | ||
003 | DE-604 | ||
005 | 20180305 | ||
007 | cr|uuu---uuuuu | ||
008 | 180305s1976 xx o|||| 00||| eng d | ||
020 | |a 0444152059 |c Amer. Elsevier |9 0-444-15205-9 | ||
020 | |a 9021940442 |c Excerpta Medica |9 90-219-4044-2 | ||
020 | |a 9780470663318 |9 978-0-470-66331-8 | ||
020 | |a 9780470717899 |c Online |9 978-0-470-71789-9 | ||
035 | |a (ZDB-38-ESG)ebr10575452 | ||
035 | |a (OCoLC)646559828 | ||
035 | |a (DE-599)BVBBV044848183 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
082 | 0 | |a 612/.0151/8 |2 22 | |
110 | 2 | |a Symposium on Monoamine Oxidase and its Inhibition <1975, London, England> |e Verfasser |4 aut | |
245 | 1 | 0 | |a Monoamine oxidase and its inhibition |b in honour of Mary L. C. Bernheim |
264 | 1 | |a Amsterdam |b Elsevier/Excerpta Medica/North-Holland |c 1976 | |
300 | |a xii, 415 p. | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Ciba Foundation symposium |v new ser. 39 | |
505 | 8 | |a Includes bibliographical references and indexes | |
505 | 8 | |a Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. | |
505 | 8 | |a The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. | |
505 | 8 | |a Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis | |
650 | 4 | |a Monoamine oxidase |v Congresses | |
650 | 4 | |a Monoamine oxidase |x Inhibitors |v Congresses | |
650 | 0 | 7 | |a Monoaminoxidase |0 (DE-588)4137008-9 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Monoaminoxidase |0 (DE-588)4137008-9 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Bernheim, Molly |d 1902-1997 |e Sonstige |4 oth | |
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
912 | |a ZDB-38-ESG | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-030243044 |
Datensatz im Suchindex
_version_ | 1823048879549972480 |
---|---|
adam_text | |
any_adam_object | |
author_corporate | Symposium on Monoamine Oxidase and its Inhibition <1975, London, England> |
author_corporate_role | aut |
author_facet | Symposium on Monoamine Oxidase and its Inhibition <1975, London, England> |
author_sort | Symposium on Monoamine Oxidase and its Inhibition <1975, London, England> |
building | Verbundindex |
bvnumber | BV044848183 |
collection | ZDB-38-ESG |
contents | Includes bibliographical references and indexes Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis |
ctrlnum | (ZDB-38-ESG)ebr10575452 (OCoLC)646559828 (DE-599)BVBBV044848183 |
dewey-full | 612/.0151/8 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 612 - Human physiology |
dewey-raw | 612/.0151/8 |
dewey-search | 612/.0151/8 |
dewey-sort | 3612 3151 18 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zcb4500</leader><controlfield tag="001">BV044848183</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180305</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180305s1976 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0444152059</subfield><subfield code="c">Amer. Elsevier</subfield><subfield code="9">0-444-15205-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9021940442</subfield><subfield code="c">Excerpta Medica</subfield><subfield code="9">90-219-4044-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470663318</subfield><subfield code="9">978-0-470-66331-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470717899</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-470-71789-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-ESG)ebr10575452</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)646559828</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044848183</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">612/.0151/8</subfield><subfield code="2">22</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Symposium on Monoamine Oxidase and its Inhibition <1975, London, England></subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Monoamine oxidase and its inhibition</subfield><subfield code="b">in honour of Mary L. C. Bernheim</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam</subfield><subfield code="b">Elsevier/Excerpta Medica/North-Holland</subfield><subfield code="c">1976</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xii, 415 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Ciba Foundation symposium</subfield><subfield code="v">new ser. 39</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Includes bibliographical references and indexes</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoamine oxidase</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoamine oxidase</subfield><subfield code="x">Inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Monoaminoxidase</subfield><subfield code="0">(DE-588)4137008-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Monoaminoxidase</subfield><subfield code="0">(DE-588)4137008-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bernheim, Molly</subfield><subfield code="d">1902-1997</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-38-ESG</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030243044</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV044848183 |
illustrated | Not Illustrated |
indexdate | 2025-02-03T15:01:33Z |
institution | BVB |
isbn | 0444152059 9021940442 9780470663318 9780470717899 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030243044 |
oclc_num | 646559828 |
open_access_boolean | |
physical | xii, 415 p. |
psigel | ZDB-38-ESG |
publishDate | 1976 |
publishDateSearch | 1976 |
publishDateSort | 1976 |
publisher | Elsevier/Excerpta Medica/North-Holland |
record_format | marc |
series2 | Ciba Foundation symposium |
spelling | Symposium on Monoamine Oxidase and its Inhibition <1975, London, England> Verfasser aut Monoamine oxidase and its inhibition in honour of Mary L. C. Bernheim Amsterdam Elsevier/Excerpta Medica/North-Holland 1976 xii, 415 p. txt rdacontent c rdamedia cr rdacarrier Ciba Foundation symposium new ser. 39 Includes bibliographical references and indexes Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis Monoamine oxidase Congresses Monoamine oxidase Inhibitors Congresses Monoaminoxidase (DE-588)4137008-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Monoaminoxidase (DE-588)4137008-9 s 1\p DE-604 Bernheim, Molly 1902-1997 Sonstige oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Monoamine oxidase and its inhibition in honour of Mary L. C. Bernheim Includes bibliographical references and indexes Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis Monoamine oxidase Congresses Monoamine oxidase Inhibitors Congresses Monoaminoxidase (DE-588)4137008-9 gnd |
subject_GND | (DE-588)4137008-9 (DE-588)1071861417 |
title | Monoamine oxidase and its inhibition in honour of Mary L. C. Bernheim |
title_auth | Monoamine oxidase and its inhibition in honour of Mary L. C. Bernheim |
title_exact_search | Monoamine oxidase and its inhibition in honour of Mary L. C. Bernheim |
title_full | Monoamine oxidase and its inhibition in honour of Mary L. C. Bernheim |
title_fullStr | Monoamine oxidase and its inhibition in honour of Mary L. C. Bernheim |
title_full_unstemmed | Monoamine oxidase and its inhibition in honour of Mary L. C. Bernheim |
title_short | Monoamine oxidase and its inhibition |
title_sort | monoamine oxidase and its inhibition in honour of mary l c bernheim |
title_sub | in honour of Mary L. C. Bernheim |
topic | Monoamine oxidase Congresses Monoamine oxidase Inhibitors Congresses Monoaminoxidase (DE-588)4137008-9 gnd |
topic_facet | Monoamine oxidase Congresses Monoamine oxidase Inhibitors Congresses Monoaminoxidase Konferenzschrift |
work_keys_str_mv | AT symposiumonmonoamineoxidaseanditsinhibition1975londonengland monoamineoxidaseanditsinhibitioninhonourofmarylcbernheim AT bernheimmolly monoamineoxidaseanditsinhibitioninhonourofmarylcbernheim |